Given the fact that epigenetic modifiers harness intermediates or products of key cellular metabolic processes as their cofactors/substrates, regulation of epigenetics by cellular metabolism represents a common biological process (Figure 1) (3), which can disrupt adequate immune responses by CD8+ T cells during anti-viral and anti-tumor immune responses (3). The gene discussed is CD8A; the disease is neoplasm.